Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Thoracic Surgery

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 30 articles:
HTML format



Single Articles


    April 2022
  1. SAJI H, Okada M, Tsuboi M, Nakajima R, et al
    Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
    Lancet. 2022;399:1607-1617.
    PubMed     Abstract available


  2. LICHT PB
    When less is more in thoracic surgery.
    Lancet. 2022;399:1574-1575.
    PubMed    


  3. SEKULIC SP, Sekulic M
    Atypical arrhythmogenic presentation of giant cell myocarditis diagnosed after heart transplant.
    Lancet. 2022;399:1411.
    PubMed    


  4. BORGES FK, Spence J
    Challenging dogma about perioperative warming during non-cardiac surgery.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00607.
    PubMed    


  5. SESSLER DI, Pei L, Li K, Cui S, et al
    Aggressive intraoperative warming versus routine thermal management during non-cardiac surgery (PROTECT): a multicentre, parallel group, superiority trial.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00560.
    PubMed     Abstract available


    February 2022
  6. THEODOROPOULOS KC, Liakopoulou A, Tsagkaropoulos S, Kassimis G, et al
    Under-sensing by a temporary pacemaker after cardiac surgery and ventricular fibrillation.
    Lancet. 2022;399:677.
    PubMed    


  7. BODEN WE, Kaski JC, Al-Lamee R, Weintraub WS, et al
    What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?
    Lancet. 2022;399:691-694.
    PubMed    


    January 2022
  8. BURKI T
    Pig-heart transplantation surgeons look to the next steps.
    Lancet. 2022;399:347.
    PubMed    


    November 2021
  9. SABATINE MS, Bergmark BA, Murphy SA, O'Gara PT, et al
    Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02334.
    PubMed     Abstract available


  10. MEHRAN R, Owen R, Chiarito M, Baber U, et al
    A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02326.
    PubMed     Abstract available


  11. GAUDINO M, Sanna T, Ballman KV, Robinson NB, et al
    Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02490.
    PubMed     Abstract available


  12. BELLEY-COTE EP, Devereaux PJ
    PCI versus CABG for left main coronary artery disease: is the jury still out?
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02491.
    PubMed    


  13. VAN BOVEN WJ, de Groot JR, Kluin J
    A short cut to prevent postoperative atrial fibrillation.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02435.
    PubMed    


  14. KANG J, Koo BK, Park KW, Shin ES, et al
    Aspirin versus clopidogrel after percutaneous coronary intervention - Authors' reply.
    Lancet. 2021;398:1685-1686.
    PubMed    


  15. PAREEK M, Byrne C
    Aspirin versus clopidogrel after percutaneous coronary intervention.
    Lancet. 2021;398:1685.
    PubMed    


  16. BYRNE RA, McGovern L
    Angiography-derived quantitative flow ratio guidance of coronary intervention: measure twice, cut once.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02397.
    PubMed    


  17. XU B, Tu S, Song L, Jin Z, et al
    Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02248.
    PubMed     Abstract available


    October 2021
  18. KIM CJ, Park MW, Kim MC, Choo EH, et al
    Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised tr
    Lancet. 2021;398:1305-1316.
    PubMed     Abstract available


    June 2021
  19. DESHPANDE AA, Sharma V, Bansal R, Jagia P, et al
    Tension pericardial abscess in a patient with tuberculosis: a rare cause of cardiac tamponade.
    Lancet. 2021;397:e15.
    PubMed    


    May 2021
  20. KOO BK, Kang J, Park KW, Rhee TM, et al
    Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)01063.
    PubMed     Abstract available


    April 2021
  21. SIBBING D, Kastrati A
    Guided P2Y12 inhibitor therapy after percutaneous coronary intervention.
    Lancet. 2021;397:1423-1425.
    PubMed    


  22. GALLI M, Benenati S, Capodanno D, Franchi F, et al
    Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Lancet. 2021;397:1470-1483.
    PubMed     Abstract available


    December 2020
  23. MUNOZ M, Gomez-Ramirez S, Rondinelli MB, Weltert L, et al
    Preoperative intravenous iron for cardiac surgery.
    Lancet. 2020;396:1884.
    PubMed    


  24. MYLES PS, Richards T, Klein A
    Preoperative intravenous iron for cardiac surgery.
    Lancet. 2020;396:1883-1884.
    PubMed    


    November 2020
  25. SILVAIN J, Lattuca B, Beygui F, Range G, et al
    Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32236.
    PubMed     Abstract available


    October 2020
  26. JEGER RV, Farah A, Ohlow MA, Mangner N, et al
    Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32173.
    PubMed     Abstract available


  27. TAKAHASHI K, Serruys PW, Fuster V, Farkouh ME, et al
    Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNT
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32114.
    PubMed     Abstract available


    September 2020
  28. MAKKAR RR, Cheng W, Waksman R, Satler LF, et al
    Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
    Lancet. 2020;396:669-683.
    PubMed     Abstract available


    August 2020
  29. LIANG F, Wang X, Wang Q, Yan P, et al
    Predilatation and paravalvular leakage risk in TAVR.
    Lancet. 2020;396:600.
    PubMed    


  30. LANZ J, Kunzi A, Windecker S, Pilgrim T, et al
    Predilatation and paravalvular leakage risk in TAVR - Authors' reply.
    Lancet. 2020;396:600-601.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: